| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
|
Nat Genet
|
2006
|
8.32
|
|
2
|
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.
|
J Clin Invest
|
2007
|
4.09
|
|
3
|
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.
|
J Clin Invest
|
2008
|
2.69
|
|
4
|
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
|
Blood
|
2008
|
2.01
|
|
5
|
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
|
J Clin Endocrinol Metab
|
2008
|
1.92
|
|
6
|
DRAGON, a bone morphogenetic protein co-receptor.
|
J Biol Chem
|
2005
|
1.89
|
|
7
|
Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium.
|
Exp Biol Med (Maywood)
|
2002
|
1.67
|
|
8
|
Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3.
|
Endocrinology
|
2005
|
1.59
|
|
9
|
FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults.
|
Proc Natl Acad Sci U S A
|
2007
|
1.55
|
|
10
|
Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
|
J Biol Chem
|
2007
|
1.45
|
|
11
|
Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.
|
Endocrinology
|
2008
|
1.27
|
|
12
|
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.
|
Am J Hum Genet
|
2013
|
1.26
|
|
13
|
A genetic basis for functional hypothalamic amenorrhea.
|
N Engl J Med
|
2011
|
1.24
|
|
14
|
Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.
|
J Clin Endocrinol Metab
|
2009
|
1.22
|
|
15
|
Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
|
J Clin Endocrinol Metab
|
2012
|
1.18
|
|
16
|
The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
|
Endocr Rev
|
2010
|
1.16
|
|
17
|
Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay.
|
J Clin Endocrinol Metab
|
2004
|
1.12
|
|
18
|
The role of follistatin domains in follistatin biological action.
|
Mol Endocrinol
|
2003
|
1.01
|
|
19
|
Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.
|
Mol Endocrinol
|
2004
|
1.00
|
|
20
|
Structure of myostatin·follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding.
|
J Biol Chem
|
2011
|
1.00
|
|
21
|
The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity.
|
J Biol Chem
|
2008
|
0.99
|
|
22
|
Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.
|
Mol Cell Biol
|
2012
|
0.96
|
|
23
|
Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).
|
Endocrinology
|
2003
|
0.95
|
|
24
|
Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.
|
J Biol Chem
|
2004
|
0.95
|
|
25
|
Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis.
|
Endocrinology
|
2005
|
0.93
|
|
26
|
Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis.
|
Obesity (Silver Spring)
|
2011
|
0.93
|
|
27
|
The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice.
|
Endocrinology
|
2009
|
0.90
|
|
28
|
Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
|
J Endocrinol
|
2007
|
0.88
|
|
29
|
Differential actions of follistatin and follistatin-like 3.
|
Mol Cell Endocrinol
|
2004
|
0.87
|
|
30
|
The puzzles of the prokineticin 2 pathway in human reproduction.
|
Mol Cell Endocrinol
|
2011
|
0.79
|
|
31
|
Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH).
|
Gene
|
2012
|
0.78
|
|
32
|
Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism.
|
Endocr Rev
|
2009
|
0.76
|